Amy is the mother of a 22-year-old daughter who has lived with type 1 diabetes since age 10. She told us how early on, she was eager to enroll her daughter in research studies in the hope that it might lead to a cure for her child.
Pharmaceutical giant Abbott Laboratories announced Wednesday that its longtime CEO, Miles White, would be stepping down effective in March 2020, closing out a 21-year tenure at the helm of the 131-year-old company.
In the spirit of resilience and bravery that they exhibit, here's a video of some of the kids we met telling us the one thing that they want people who don't have type 1 diabetes to know about the lifelong chronic condition.
As important, but perhaps less broadly publicized than the financial burden, is the daily mental and logistical toll diabetes exacts on patients and families. Diabetes affects more than simply blood sugars - it also disrupts sleep, work schedules, social life, and more.
Unfortunately for young people with type 1 diabetes, we still don't have a straightforward screening or genetic test for the disease, which has both environmental and complex hereditary components. A research team at UVA is working to change that.
A new study published in the New England Journal of Medicine (NEJM) showed promising results for closed-loop insulin delivery systems, the journal and participating manufacturers reported last week.